GlassScriptPhysician profile
Emily A Malm
NPI 1801128681
$32,476.96
in general payments reported to CMS, 2019-2025
52 companies · $49.56 in 2025
The $49.56 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,813 · 2022: $11K · 2023: $7,921 · 2024: $5,892 · 2025: $49.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,845 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,963 · Travel and Lodging: $55.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,844.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,962.50 |
| Travel and Lodging | $55.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20,751.13 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $926.80 | 2022-2024 | Austedo Xr, Austedo |
| Allergan, INC. | $862.57 | 2021-2022 | |
| Lundbeck LLC | $810.55 | 2022-2024 | Vyepti, Rexulti |
| Livanova USA, INC. | $782.23 | 2022-2023 | Vns Therapy |
| Alexion Pharmaceuticals, INC. | $640.40 | 2022-2024 | Ultomiris, Soliris |
| Sk Life Science, INC. | $634.33 | 2022-2024 | |
| Lilly USA, LLC | $622.32 | 2021-2024 | Amyvid, Emgality, Reyvow |
| Pfizer INC. | $568.40 | 2023-2024 | |
| Ucb, INC. | $520.30 | 2021-2024 | Briviact, Fintepla |
| Biohaven Pharmaceutical Holding Company LTD. | $509.32 | 2022 | |
| Neurocrine Biosciences, INC. | $395.07 | 2021-2024 | Ingrezza |
| Eisai INC. | $365.93 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $359.81 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $336.39 | 2023-2024 | Dysport |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $326.18 | 2022-2024 | Vyvgart, Vyvgart Hytrulo |
| Takeda Pharmaceuticals U.S.A., INC. | $303.30 | 2022-2024 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $287.10 | 2023-2024 | Nuedexta |
| Amneal Pharmaceuticals LLC | $283.98 | 2022-2024 | Rytary, Crexont |
| Merz Pharmaceuticals, LLC | $235.72 | 2023-2024 | Xeomin, Inbrija |
| Amgen INC. | $233.11 | 2021-2023 | Aimovig |
| Avanir Pharmaceuticals, INC. | $171.51 | 2022 | |
| Mdd US Operations, LLC | $143.00 | 2022-2024 | Gocovri, Gocovri |
| Catalyst Pharmaceuticals, INC. | $117.69 | 2023-2024 | Fycompa |
| Novartis Pharmaceuticals Corporation | $103.11 | 2021-2022 | |
| Tersera Therapeutics LLC | $102.95 | 2022-2024 | Quzyttir |
| Scilex Pharmaceuticals INC. | $95.16 | 2023-2024 | Ztlido |
| Kyowa Kirin, INC. | $83.69 | 2024 | Nourianz |
| Tanabe Pharma America, INC. | $81.73 | 2022-2024 | |
| Immedica Pharma US, INC. | $76.34 | 2023-2024 | |
| Acadia Pharmaceuticals INC | $57.19 | 2022-2023 | Daybue |
| Sumitomo Pharma America, INC. | $55.66 | 2024 | Aptiom |
| Alnylam Pharmaceuticals INC. | $54.48 | 2022-2024 | Amvuttra |
| Idorsia Pharmaceuticals US INC | $51.96 | 2022-2024 | Quviviq |
| Azurity Pharmaceuticals, INC. | $50.48 | 2023 | Horizant |
| Csl Behring | $46.17 | 2022-2023 | Hizentra |
| Medtronic, INC. | $45.00 | 2022 | |
| Impel Pharmaceuticals INC. | $39.81 | 2023 | Trudhesa |
| Corium, LLC | $39.15 | 2022-2023 | Adlarity |
| Aquestive Therapeutics, INC. | $36.98 | 2021 | |
| Octapharma USA, INC. | $34.17 | 2023-2024 | Octagam Immune Globulin (Human), Panzyga |
| Sandoz INC. | $32.63 | 2023 | |
| Neurelis, INC. | $31.02 | 2024 | Valtoco |
| Biogen, INC. | $29.73 | 2024 | Skyclarys |
| Banner Life Sciences, LLC | $27.28 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $24.01 | 2023 | Lumryz |
| Acorda Therapeutics, INC | $22.62 | 2022 | |
| Abbott Laboratories | $17.32 | 2022 | |
| Emd Serono, INC. | $16.00 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.92 | 2022 | |
| Microtransponder, INC. | $14.20 | 2023 | |
| Grt US Holding, INC. | $6.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Malm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.